Data / Form D filings / Hallux, Inc.
Hallux, Inc.: Form D filings
Hallux, Inc., a pharmaceuticals company in Laguna Hills, CA, filed 5 Form D notices with the SEC between 2015 and 2023. The latest, on April 26, 2023, reports $10.7 million sold of a $11 million offering to 18 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 23052 ALCALDE DRIVE, SUITE A, Laguna Hills, CA, 92653
- Phone
- (949) 313-7718
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1658324
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 26, 2023 | Amendment | $11,043,445 | $10,709,025 | $334,420 | 18 | Mar 31, 2022 | sec.gov |
| Apr 13, 2022 | New notice | $11,043,445 | $9,404,835 | $1,638,610 | 17 | Mar 31, 2022 | sec.gov |
| Jan 14, 2020 | Amendment | $3,700,000 | $2,205,000 | $1,495,000 | 12 | Nov 1, 2018 | sec.gov |
| Nov 16, 2018 | New notice | $2,500,000 | $1,255,000 | $1,245,000 | 8 | Nov 1, 2018 | sec.gov |
| Dec 14, 2015 | New notice | $7,093,675 | $7,093,675 | 20 | Dec 4, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Taylor | Executive Officer, Director | |
| Seth Birnbaum | Director | |
| William Forbes | Director | |
| Robert Orr | Director | |
| Jay Birnbaum | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Apr 24, 2023 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Hallux, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.